The current US healthcare system falls short in utilizing healthcare economic information (HCEI) to accurately manage spending on prescription drugs, diagnostics, and devices.

This article describes how recent FDA guidance and improved HCEI communication between drug manufacturers and payers help create a formulary and budgeting framework that could translate to more affordable access to drugs for patients.

View Article